Latest News about bluebird bio, Inc/
Recent news which mentions bluebird bio, Inc/
Cell and gene therapy firm raises $170M investment
March 30, 2020
From Business Journals
From Business Journals
Blood disorder startup files for $86M IPO
February 19, 2020
From Business Journals
Acceleron stock soars on lung drug trial data
January 28, 2020
From Business Journals
CRISPR Therapeutics stock jumps on early gene editing data
November 19, 2019
From Business Journals
FDA approves Acceleron's blood disorder drug ahead of schedule
November 08, 2019
From Business Journals
These 36 Mass. firms made Deloitte's Technology Fast 500
November 07, 2019
From Business Journals
From Business Journals
From Business Journals
From Business Journals
Here's how much top biotechs spent on R&D last quarter
June 10, 2019
Tags
bluebird bio Inc/ (Cambridge MA)
Sage Therapeutics Inc/ (Cambridge MA)
Vertex Pharmaceuticals Incorporated
From Business Journals
From Business Journals
From Business Journals
13 local life sciences drugs and devices to watch in 2019
January 01, 2019
From Business Journals
From Business Journals
From Business Journals
From Business Journals
Spark Therapeutics, Bluebird CEOs formulate a Super Bowl wager
February 02, 2018
From Business Journals
Cambridge biotechs among big winners at ASH blood disease conference
December 10, 2017
From Business Journals
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.